Key findings on plasma cell disorders to be presented at American Society of Hematology Annual Meeting

September 12, 2015

"In addition to providing industry-leading diagnostic pathology, Caris Life Sciences is dedicated to engaging the scientific community by furthering research across a broad array of specialties, including hematology," said Dr. Richard Lash, Caris Life Sciences' Head Pathologist and Chief Medical Officer. "Dr. Braylan's research demonstrates how optimizing our techniques can significantly enhance our ability to diagnose plasma cell disorders, despite the rarity of the abnormal cells, and provide physicians valuable and timely information to support patient care."

Dr. Braylan is recognized as one of the world's foremost authorities on flow cytometry in hematolymphoid neoplasia, and he is credited with establishing standardization in flow cytometry clinical utility, data analysis and reporting through his work on both the U.S. and Canadian Consensus Recommendations and the 2006 Bethesda International Conference Recommendations for flow cytometric immunophenotyping.

The abstract of Dr. Braylan's poster, which will be presented Saturday, December 4, at the 2010 American Society of Hematology Annual Meeting in Orlando, FL, can be found on the ASH website.

SOURCE  Caris Life Sciences, Inc.